Clinical trial

MRI Guided Radiation Therapy for the Treatment of High Risk Prostate Cancer

NCT05676463

StatusTERMINATED

Study typeINTERVENTIONAL

Start date2022-11-16

PhasePHASE2

Study timeline

Study start (actual)2022-11-16Date precision: day

Registry last updated2026-03-03

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Prostate Adenocarcinomaunresolved

Stage IIIB Prostate Cancer AJCC v8unresolved

Stage IIIC Prostate Cancer AJCC v8unresolved

Interventions

MRI-guided Intensity-Modulated Radiation TherapyPROCEDURE

Antiandrogen TherapyDRUG

PSMA PET ScanPROCEDURE

Computed TomographyPROCEDURE

Magnetic Resonance ImagingPROCEDURE

Bone ScanPROCEDURE

Biospecimen CollectionPROCEDURE

Quality-of-Life AssessmentOTHER

Sponsors & collaborators

Thomas Jefferson Universitylead sponsor

Mapped research locations

PhiladelphiaPennsylvania, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT05676463 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.